Actiphage™ is based on technology, developed by Drs Cath Rees and Ben Swift at the University of Nottingham, it detects the presence of live mycobacteria.
Includes: Mycobacterium bovis (bovine TB): Mycobacterium avium subsp. paratuberculosis (MAP; Johne’s disease), which are significant causes of morbidity and loss of productivity in cattle.
Uniquely the technology can differentiate between vaccinated animals and those carrying live infectious organisms.
We have developed highly specific and sensitive assays for the cost-effective detection of MAP and bovine tuberculosis in multiple tissue types including blood, milk and faeces.
Assays are available as standard laboratory tests (48 hours) or in a simple, single-day, sample-to-result format.
The assays can be used for infection control and as part of a quality assurance programme to ensure the absence of infection in non-pasteurised products.
In addition, the method can be adapted to detect other types of mycobacteria and applied to infections in other animal hosts including deer, goats, camelids and exotic species.